PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor
Abstract The Published Kinase Inhibitor Set (PKIS) is a publicly-available chemogenomic library distributed to more than 300 laboratories by GlaxoSmithKline (GSK) between 2011 and 2015 and by SGC-UNC from 2015 to 2017. Screening this library of well-annotated, published kinase inhibitors has yielded...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/2427271ceabc4a4d9e480023fca08c5f |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|